From the Department of Anesthesiology, Stony Brook Renaissance School of Medicine, Stony Brook, New York.
Department of Anesthesiology, Texas A&M College of Medicine, Temple, Texas.
Anesth Analg. 2022 Nov 1;135(5):986-1000. doi: 10.1213/ANE.0000000000006126. Epub 2022 Sep 1.
Although prophylactic antiemetics are commonly used perioperatively, an estimated 30% of surgical patients still suffer from postoperative nausea and vomiting (PONV). Very few prospective trials have studied rescue treatment of PONV after failure of prophylaxis, providing limited evidence to support clinical management. In patients who have failed PONV prophylaxis, administering a rescue antiemetic from the same drug class has been reported to be ineffective. For many antiemetics currently used in PONV rescue, significant uncertainty remains around the effective dose range, speed of onset, duration of effect, safety, and overall risk-benefit ratio. As prompt, effective PONV rescue after failure of prophylaxis is important to optimize postoperative recovery and resource utilization, we conduct this systematic review to summarize the current evidence available on the topic.
尽管预防性止吐药在围手术期通常被广泛应用,但估计仍有 30%的手术患者会发生术后恶心和呕吐(PONV)。只有极少数前瞻性试验研究了预防失败后 PONV 的抢救治疗,这为临床管理提供的证据有限。对于预防失败的患者,使用相同药物类别的抢救性止吐药已被报道无效。对于目前在 PONV 抢救中使用的许多止吐药,其有效剂量范围、起效速度、作用持续时间、安全性和总体风险效益比仍然存在很大的不确定性。由于及时、有效地抢救治疗预防失败后的 PONV 对于优化术后恢复和资源利用非常重要,因此我们进行了这项系统评价,以总结该主题的现有证据。